A non-core eye care business that was spun off from Novartis.
AI-generated insights about Alcon Inc. from various financial sources
Mentioned as a non-core business spun off by Novartis as part of a strategy that unlocked approximately $180 billion in shareholder value.
Mentioned as a non-core business spun off by Novartis as part of a strategy that unlocked approximately $180 billion in shareholder value.